Adelia R. Iskalieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adelia R. Iskalieva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Guadalupe Martinez Salvador
Санкт-Петербургский государственный педиатрический медицинский университет
1 shared publication - Karim Ahmed R. Moustafa
Санкт-Петербургский государственный педиатрический медицинский университет
1 shared publication - Nadezhda G. Kolesnikova
Санкт-Петербургский государственный педиатрический медицинский университет
1 shared publication - Nikanor V. Lavrov
Institute of Experimental Medicine; St. Petersburg State Medical Pediatric University
1 shared publication - Olga Leonidovna Krasnogorskaya
Saint Petersburg State Pediatric Medical University
1 shared publication - Pavel A. Aleksandrov
O-Tri Medical Center (Treatment and Preventive Center of the St. Petersburg Institute of Restorative Medicine and Rehabilitation OOO (limited liability company)
1 shared publication
Latest Publications
- Open Access
- 23 April 2025
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
- Vol. 15 (1) , 19-26
Morphological aspects of surgical treatment for anal achalasia in children
BACKGROUND: The primary clinical manifestations of anal achalasia include constipation and, in advanced cases, overflow incontinence, which require differentiation from other conditions. Differential diagnosis between these conditions often depends solely on the histological examination results of the internal anal sphincter, which are insufficiently covered in the literature. Treatment options for pediatric anal achalasia include botulinum toxin injections, although sphincterotomy remains the most effective method. However, factors determining the efficacy of internal sphincterotomy, particularly related to histological features, remain poorly understood. AIM: To analyze surgical outcomes and assess the condition of the ganglionic cells of the anal canal and rectum in children with anal achalasia. MATERIALS AND METHODS: The study included 64 pediatric patients who underwent internal sphincterotomy involving excision and histological examination of a 4 cm × 1 cm segment of the underlying muscular layer (Lynn’s procedure). RESULTS: Positive clinical outcomes, characterized by daily bowel movements and resolution of overflow incontinence, were achieved in 39 patients. Conversely, 25 patients showed persistent constipation and/or overflow incontinence postoperatively. Histological examination revealed a significant increase in connective tissue within the internal anal sphincter. However, in patients with and without a positive outcome after internal sphincterotomy, the total number of neurons and interneurons at +3 cm and +5 cm from the anus was approximately the same. Rectal dilation persisted in 100% of patients with unsuccessful outcomes, whereas a reduction in previously dilated rectal diameter was noted among patients with successful outcomes. CONCLUSIONS: Anal achalasia is characterized by at least a threefold reduction in neuron count within the internal anal sphincter compared to normal. However, surgical outcomes were independent of the total number of neurons and interneurons. A nonlinear relationship in the number of ganglion cells was identified in the resected segments of the internal sphincter muscle, with an increasing density from the distal to the proximal part. Persistent rectal dilation following Lynn’s procedure was inversely correlated with treatment efficacy in patients with anal achalasia who did not achieve a positive outcome.
- 23 April 2025
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
- Vol. 15 (1) , 19-26
Open AccessMorphological aspects of surgical treatment for anal achalasia in children
BACKGROUND: The primary clinical manifestations of anal achalasia include constipation and, in advanced cases, overflow incontinence, which require differentiation from other conditions. Differential diagnosis between these conditions often depends solely on the histological examination results of the internal anal sphincter, which are insufficiently covered in the literature. Treatment options for pediatric anal achalasia include botulinum toxin injections, although sphincterotomy remains the most effective method. However, factors determining the efficacy of internal sphincterotomy, particularly related to histological features, remain poorly understood. AIM: To analyze surgical outcomes and assess the condition of the ganglionic cells of the anal canal and rectum in children with anal achalasia. MATERIALS AND METHODS: The study included 64 pediatric patients who underwent internal sphincterotomy involving excision and histological examination of a 4 cm × 1 cm segment of the underlying muscular layer (Lynn’s procedure). RESULTS: Positive clinical outcomes, characterized by daily bowel movements and resolution of overflow incontinence, were achieved in 39 patients. Conversely, 25 patients showed persistent constipation and/or overflow incontinence postoperatively. Histological examination revealed a significant increase in connective tissue within the internal anal sphincter. However, in patients with and without a positive outcome after internal sphincterotomy, the total number of neurons and interneurons at +3 cm and +5 cm from the anus was approximately the same. Rectal dilation persisted in 100% of patients with unsuccessful outcomes, whereas a reduction in previously dilated rectal diameter was noted among patients with successful outcomes. CONCLUSIONS: Anal achalasia is characterized by at least a threefold reduction in neuron count within the internal anal sphincter compared to normal. However, surgical outcomes were independent of the total number of neurons and interneurons. A nonlinear relationship in the number of ganglion cells was identified in the resected segments of the internal sphincter muscle, with an increasing density from the distal to the proximal part. Persistent rectal dilation following Lynn’s procedure was inversely correlated with treatment efficacy in patients with anal achalasia who did not achieve a positive outcome.
- Open Access
- 20 October 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (5) , 39-47
Toxocarosis in children: unresolved issues of clinic, diagnosis and treatment
Toxocariasis is a widespread zoonotic parasitic invasion, with a fecal-oral transmission mechanism, occurring in humans exclusively in the form of tissue parasitism of the larval stage of Toxocara spp. (biological dead end) and manifests itself in the form of toxic-allergic reactions of varying severity and multiple organ lesions, that depends on the number and location of the parasites. It is more common for children due to regular contact with soil when they play in public parks and playgrounds contaminated with Toxocara eggs, that have tendency to a long-term relapsing course. There is no doubt about the existence of clinical manifest toxocariasis, which is manifested by fever, nonproductive cough, allergic rashes and hypereosinophilia in combination with a high level of antibodies to toxocariasis, however, there are still conflicting data on the impact on the general health of children who are seropositive for toxocariasis with low coefficients, in the absence of a significant increase in the level of peripheral blood eosinophils, i.e. the so-called “toxocara carrier”. It is an important task in practical healthcare to update the concept of low-intensity, because of increasing number of children with immune-related disorders, increased allergenic background, and skin diseases. Toxocara infestation. The article provides literature review of the problem of identifying, clinical and laboratory assessment of the course of toxocariasis and toxocara carriage, the impact of these conditions on the health and premorbid background of children, including children with low level of specific antibodies, and big choice of etiotropic therapy.
- 20 October 2024
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 15 (5) , 39-47
Open AccessToxocarosis in children: unresolved issues of clinic, diagnosis and treatment
Toxocariasis is a widespread zoonotic parasitic invasion, with a fecal-oral transmission mechanism, occurring in humans exclusively in the form of tissue parasitism of the larval stage of Toxocara spp. (biological dead end) and manifests itself in the form of toxic-allergic reactions of varying severity and multiple organ lesions, that depends on the number and location of the parasites. It is more common for children due to regular contact with soil when they play in public parks and playgrounds contaminated with Toxocara eggs, that have tendency to a long-term relapsing course. There is no doubt about the existence of clinical manifest toxocariasis, which is manifested by fever, nonproductive cough, allergic rashes and hypereosinophilia in combination with a high level of antibodies to toxocariasis, however, there are still conflicting data on the impact on the general health of children who are seropositive for toxocariasis with low coefficients, in the absence of a significant increase in the level of peripheral blood eosinophils, i.e. the so-called “toxocara carrier”. It is an important task in practical healthcare to update the concept of low-intensity, because of increasing number of children with immune-related disorders, increased allergenic background, and skin diseases. Toxocara infestation. The article provides literature review of the problem of identifying, clinical and laboratory assessment of the course of toxocariasis and toxocara carriage, the impact of these conditions on the health and premorbid background of children, including children with low level of specific antibodies, and big choice of etiotropic therapy.
- Open Access
- 28 December 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in University therapeutic journal
- Vol. 5 (3) , 137-143
CLINICAL CASE OF DIPHYLLOBOTHRIOSIS
Дифиллоботриоз — один из самых распространенных гельминтозов на территории Северного полушария. В Российской Федерации частота встречаемости дифиллоботриоза колеблется от 10 до 180 на 100 тыс. населения. Среди заболевших преобладают взрослые и подростки, однако в последнее время участились случаи заражения детей младшего возраста. Вследствие неполного сбора анамнеза, недооценки данных лабораторных исследований диагноз дифиллоботриоза устанавливается поздно. Отсроченное начало противопаразитарной терапии и отсутствие доказательной базы относительно подбора дозы празиквантела для детей младше 4 лет делают проблему еще более актуальной. В данной работе представлен нераспознанный на первичном этапе оказания медицинской помощи клинический случай дифиллоботриоза у ребенка 3,5 лет. Авторы статьи обращают внимание читателей на важность клинической интерпретации лабораторных данных в соответствии с имеющейся клинико-эпидемиологической ситуацией и делятся опытом успешного подбора терапевтической дозы празиквантела при лечении дифиллоботриоза у детей младше 4 лет.
- 28 December 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in University therapeutic journal
- Vol. 5 (3) , 137-143
Open AccessCLINICAL CASE OF DIPHYLLOBOTHRIOSIS
Дифиллоботриоз — один из самых распространенных гельминтозов на территории Северного полушария. В Российской Федерации частота встречаемости дифиллоботриоза колеблется от 10 до 180 на 100 тыс. населения. Среди заболевших преобладают взрослые и подростки, однако в последнее время участились случаи заражения детей младшего возраста. Вследствие неполного сбора анамнеза, недооценки данных лабораторных исследований диагноз дифиллоботриоза устанавливается поздно. Отсроченное начало противопаразитарной терапии и отсутствие доказательной базы относительно подбора дозы празиквантела для детей младше 4 лет делают проблему еще более актуальной. В данной работе представлен нераспознанный на первичном этапе оказания медицинской помощи клинический случай дифиллоботриоза у ребенка 3,5 лет. Авторы статьи обращают внимание читателей на важность клинической интерпретации лабораторных данных в соответствии с имеющейся клинико-эпидемиологической ситуацией и делятся опытом успешного подбора терапевтической дозы празиквантела при лечении дифиллоботриоза у детей младше 4 лет.